Skip to main contentSkip to main content

Peptide Testing for Compounding Pharmacies

Independent identity, purity, endotoxin, and contaminant testing for 503A and 503B pharmacies. Audit-ready COAs in 9–11 business days.

What We Test for Pharmacies

Identity Confirmation

Mass spectrometry confirms each peptide matches its labeled sequence and molecular weight before compounding.

Purity by HPLC

Reversed-phase HPLC quantifies main-peak purity and characterizes deletion sequences and synthesis impurities.

LAL Endotoxin

Quantitative endotoxin testing in EU/mg for injectable peptide preparations.

Heavy Metals (ICP-MS)

Trace screening for lead, mercury, arsenic, and cadmium at parts-per-billion sensitivity.

Residual Solvents

GC-MS detection of TFA, DMF, DCM, and acetonitrile remaining from synthesis.

Lot Release Testing

Recurring programs for ongoing lot-by-lot release with predictable turnaround.

Why Pharmacies Choose ACS

US-based, single facility

All testing runs at our Florida lab. No samples shipped overseas, no chain-of-custody gaps.

Inspection-ready documentation

COAs include methods, instrument data, acceptance criteria, and analyst signature for state board and FDA review.

Bulk and recurring pricing

Volume pricing for ongoing release programs, with predictable monthly invoicing.

Direct chemist contact

Talk to the analyst running your sample. No call-center, no offshore handoff.

Pharmacy FAQ

Set up a pharmacy testing program

Tell us about your peptide line and lot volume. We'll return a tailored quote within one business day.